Several high-profile papers on Covid-19 research have come under fire from people in the scientific community in recent weeks. Two articles addressing the safety of certain drugs when taken by Covid-19 patients were retracted (https://www.nytimes.com/2020/06/04/health/coronavirus-hydroxychloroquine.html), and researchers are calling for the retraction of a third paper that evaluated behaviours that mitigate coronavirus transmission (https://metrics.stanford.edu/PNAS%20retraction%20request%20LoE%20061820).

Some people are viewing the retractions as an indictment of the scientific process (https://www.wsj.com/articles/the-lancets-politicized-science-on-antimalarial-drugs-11591053222?cx_testId=3&cx_testVariant=cx_4&cx_artPos=0#cxrecs_s). Certainly, the overturning of these papers is bad news, and there is plenty of blame to go around...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.